UC San Diego Bioengineer Develops New Biomaterial Therapy for Treating Heart Attacks


April 18, 2014

April 18, 2014 — A University of California, San Diego scientist has developed a new biomaterial that could potentially treat heart attacks. Karen Christman, Ph.D., associate professor of bioengineering at UC San Diego Jacobs School of Engineering, has been at work on a new injectable hydrogel, which is designed to repair damaged cardiac tissue following a heart attack.

The hydrogel has been licensed to San Diego-based startup Ventrix Inc., which is planning the first human clinical trials of the technology. Christman is a co-founder of Ventrix.

In a 2013 study published in Science Translational Medicine, Christman reported the semi-solid porous gel encourages cells to repopulate areas of damaged cardiac tissue and to preserve heart function. The hydrogel forms a scaffold to repair the tissue and increases cardiac muscle.

Christman was a faculty speaker at Research Expo, a UC San Diego Jacobs School of Engineering event, on April 17, where she presented the new technology.

For more information: http://www.jacobsschool.ucsd.edu/news/news_releases/release.sfe?id=1502

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.